Anne M. Phillips - 01 Aug 2024 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Role
Director
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
Issuer symbol
SGMT
Transactions as of
01 Aug 2024
Net transactions value
$0
Form type
4
Filing time
05 Aug 2024, 16:08:24 UTC
Previous filing
27 Jun 2024
Next filing
10 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGMT Stock Option (Right to Buy) Award $0 +113,895 $0.000000 113,895 01 Aug 2024 Series A Common Stock 113,895 $3.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest and become exercisable over thirty-six (36) equal monthly installments following August 1, 2024, subject to the Reporting Person's continued service on each such vesting date.